Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azacitidine and Venetoclax in Previously Untreated Elderly AML
NCT03466294Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- May 2018
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venetoclax in acute myeloid leukemia (AML), sponsored by University of Colorado Denver. Started May 2018; status: completed.
02
Drugs
venetoclax
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT03466294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03466294.